metricas
covid
Buscar en
Archivos de la Sociedad Española de Oftalmología (English Edition)
Toda la web
Inicio Archivos de la Sociedad Española de Oftalmología (English Edition) Intravitreal clindamycin as a therapeutic alternative in severe ocular toxoplasm...
Journal Information
Vol. 94. Issue 12.
Pages 602-604 (December 2019)
Share
Share
Download PDF
More article options
Visits
1
Vol. 94. Issue 12.
Pages 602-604 (December 2019)
Short communication
Intravitreal clindamycin as a therapeutic alternative in severe ocular toxoplasmosis
Clindamicina intravítrea como alternativa terapéutica en la toxoplasmosis ocular severa
Visits
1
L. Tabuenca del Barrioa,
Corresponding author
lauratabuillueca@gmail.com

Corresponding author.
, H. Heras Muleroa, M. Mozo Cuadradoa, P. Fanlo Mateob, E. Compains Silvaa
a Servicio de Oftalmología, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain
b Servicio de Medicina Interna, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (1)
Table 1. Symptoms and signs of recurring ocular toxoplasmosis, from higher to lower frequency.
Abstract

Ocular toxoplasmosis is a disease than have severe consequences on the eyesight. The aim of this study article is to present a bilateral ocular toxoplasmosis in a sulfamide allergic patient with unilateral activation and her favourable progression with intravitreal Clindamycin and oral steroids treatment. Weekly intravitreal Clindamycin treatment is shown to be a suitable therapeutic alternative in cases of severe ocular toxoplasmosis and/or in patients with a contraindication to classical treatment. Intravitreal Clindamycin treatment is a safe alternative with favourable clinical results.

Keywords:
Toxoplasmosis
Toxoplasma gondii
Chorioretinitis
Intravitreal clindamycin
Resumen

La toxoplasmosis ocular es una enfermedad que puede tener graves consecuencias visuales. El objetivo es presentar un caso clínico de toxoplasmosis ocular bilateral severa en paciente alérgica a sulfamidas en el que la reactivación monolateral de la enfermedad responde de forma favorable ante el tratamiento con clindamicina intravítrea y corticoterapia oral. Se muestra como la administración de clindamicina mediante inyecciones intravítreas semanales supone una alternativa terapéutica segura en aquellos casos de toxoplasmosis ocular severa y/o en los que existe contraindicación para el tratamiento clásico. La clindamicina intravítrea es una alternativa terapéutica segura con resultados clínicos favorables.

Palabras clave:
Toxoplasmosis
Toxoplasma gondii
Coriorretinitis
Clindamicina intravítrea

Article

These are the options to access the full texts of the publication Archivos de la Sociedad Española de Oftalmología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Archivos de la Sociedad Española de Oftalmología (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos